HEADER TRANSCRIPTION 20-DEC-18 6IZM TITLE CRYSTAL STRUCTURE OF THE PPARGAMMA-LBD COMPLEXED WITH COMPOUND 1L COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PPAR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: PEPTIDE FROM PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR COMPND 8 GAMMA COACTIVATOR 1-ALPHA; COMPND 9 CHAIN: C; COMPND 10 SYNONYM: PPARGC-1-ALPHA,LIGAND EFFECT MODULATOR 6; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARG, NR1C3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606 KEYWDS TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR Y.MATSUI,H.HANZAWA REVDAT 3 22-NOV-23 6IZM 1 REMARK REVDAT 2 20-NOV-19 6IZM 1 JRNL REVDAT 1 27-MAR-19 6IZM 0 JRNL AUTH T.SHINOZUKA,T.TSUKADA,K.FUJII,E.TOKUMARU,Y.MATSUI, JRNL AUTH 2 S.WAKIMOTO,T.OGATA,K.ARAKI,R.SAWAMURA,N.WATANABE,M.MORI, JRNL AUTH 3 J.TANAKA JRNL TITL STRUCTURE-ACTIVITY RELATIONSHIP STUDIES OF 3- OR 4-PYRIDINE JRNL TITL 2 DERIVATIVES OF DS-6930. JRNL REF ACS MED.CHEM.LETT. V. 10 358 2019 JRNL REFN ISSN 1948-5875 JRNL PMID 30891140 JRNL DOI 10.1021/ACSMEDCHEMLETT.8B00645 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.68 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 809756.060 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.4 REMARK 3 NUMBER OF REFLECTIONS : 24740 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.225 REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2499 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2460 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2440 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2499 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0050 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.91 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3620 REMARK 3 BIN R VALUE (WORKING SET) : 0.3100 REMARK 3 BIN FREE R VALUE : 0.3410 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 421 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.017 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2213 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 171 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.15000 REMARK 3 B22 (A**2) : -3.32000 REMARK 3 B33 (A**2) : -2.84000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -4.03000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM SIGMAA (A) : 0.12 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.18 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.004 REMARK 3 BOND ANGLES (DEGREES) : 0.700 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.620 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.110 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.710 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.690 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.500 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 57.24 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : REMARK 3 ACCELRYS_CNX:LIBRARIES/TOPPAR/PROTEIN_REP.PARA REMARK 3 PARAMETER FILE 2 : ../INSIGHT/RTC-3341.PRM REMARK 3 PARAMETER FILE 3 : REMARK 3 ACCELRYS_CNX:LIBRARIES/TOPPAR/WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : ACCELRYS_CNX:LIBRARIES/TOPPAR/PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : ../INSIGHT/RTC-3341.TOP REMARK 3 TOPOLOGY FILE 3 : ACCELRYS_CNX:LIBRARIES/TOPPAR/WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6IZM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 28-DEC-18. REMARK 100 THE DEPOSITION ID IS D_1300010208. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-APR-08 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E DW REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24887 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.3 REMARK 200 DATA REDUNDANCY : 8.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05200 REMARK 200 FOR THE DATA SET : 25.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.27200 REMARK 200 FOR SHELL : 3.560 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: 3V9T REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, NASCN, TRIS-HCL, PH 8.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 27.13300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 195 REMARK 465 ARG A 196 REMARK 465 GLY A 197 REMARK 465 SER A 198 REMARK 465 HIS A 199 REMARK 465 HIS A 200 REMARK 465 HIS A 201 REMARK 465 HIS A 202 REMARK 465 HIS A 203 REMARK 465 HIS A 204 REMARK 465 GLY A 205 REMARK 465 PRO A 206 REMARK 465 LEU A 270 REMARK 465 GLN A 271 REMARK 465 GLU A 272 REMARK 465 GLN A 273 REMARK 465 SER A 274 REMARK 465 GLN C 1 REMARK 465 GLU C 2 REMARK 465 ALA C 3 REMARK 465 GLU C 4 REMARK 465 GLU C 5 REMARK 465 PRO C 6 REMARK 465 ALA C 17 REMARK 465 ASN C 18 REMARK 465 THR C 19 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 457 -5.95 -59.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue B0X A 501 DBREF 6IZM A 206 477 UNP P37231 PPARG_HUMAN 234 505 DBREF 6IZM C 1 19 UNP Q9UBK2 PRGC1_HUMAN 136 154 SEQADV 6IZM MET A 195 UNP P37231 EXPRESSION TAG SEQADV 6IZM ARG A 196 UNP P37231 EXPRESSION TAG SEQADV 6IZM GLY A 197 UNP P37231 EXPRESSION TAG SEQADV 6IZM SER A 198 UNP P37231 EXPRESSION TAG SEQADV 6IZM HIS A 199 UNP P37231 EXPRESSION TAG SEQADV 6IZM HIS A 200 UNP P37231 EXPRESSION TAG SEQADV 6IZM HIS A 201 UNP P37231 EXPRESSION TAG SEQADV 6IZM HIS A 202 UNP P37231 EXPRESSION TAG SEQADV 6IZM HIS A 203 UNP P37231 EXPRESSION TAG SEQADV 6IZM HIS A 204 UNP P37231 EXPRESSION TAG SEQADV 6IZM GLY A 205 UNP P37231 EXPRESSION TAG SEQRES 1 A 283 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY PRO GLU SEQRES 2 A 283 SER ALA ASP LEU ARG ALA LEU ALA LYS HIS LEU TYR ASP SEQRES 3 A 283 SER TYR ILE LYS SER PHE PRO LEU THR LYS ALA LYS ALA SEQRES 4 A 283 ARG ALA ILE LEU THR GLY LYS THR THR ASP LYS SER PRO SEQRES 5 A 283 PHE VAL ILE TYR ASP MET ASN SER LEU MET MET GLY GLU SEQRES 6 A 283 ASP LYS ILE LYS PHE LYS HIS ILE THR PRO LEU GLN GLU SEQRES 7 A 283 GLN SER LYS GLU VAL ALA ILE ARG ILE PHE GLN GLY CYS SEQRES 8 A 283 GLN PHE ARG SER VAL GLU ALA VAL GLN GLU ILE THR GLU SEQRES 9 A 283 TYR ALA LYS SER ILE PRO GLY PHE VAL ASN LEU ASP LEU SEQRES 10 A 283 ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL HIS GLU SEQRES 11 A 283 ILE ILE TYR THR MET LEU ALA SER LEU MET ASN LYS ASP SEQRES 12 A 283 GLY VAL LEU ILE SER GLU GLY GLN GLY PHE MET THR ARG SEQRES 13 A 283 GLU PHE LEU LYS SER LEU ARG LYS PRO PHE GLY ASP PHE SEQRES 14 A 283 MET GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN ALA SEQRES 15 A 283 LEU GLU LEU ASP ASP SER ASP LEU ALA ILE PHE ILE ALA SEQRES 16 A 283 VAL ILE ILE LEU SER GLY ASP ARG PRO GLY LEU LEU ASN SEQRES 17 A 283 VAL LYS PRO ILE GLU ASP ILE GLN ASP ASN LEU LEU GLN SEQRES 18 A 283 ALA LEU GLU LEU GLN LEU LYS LEU ASN HIS PRO GLU SER SEQRES 19 A 283 SER GLN LEU PHE ALA LYS LEU LEU GLN LYS MET THR ASP SEQRES 20 A 283 LEU ARG GLN ILE VAL THR GLU HIS VAL GLN LEU LEU GLN SEQRES 21 A 283 VAL ILE LYS LYS THR GLU THR ASP MET SER LEU HIS PRO SEQRES 22 A 283 LEU LEU GLN GLU ILE TYR LYS ASP LEU TYR SEQRES 1 C 19 GLN GLU ALA GLU GLU PRO SER LEU LEU LYS LYS LEU LEU SEQRES 2 C 19 LEU ALA PRO ALA ASN THR HET B0X A 501 30 HETNAM B0X 3-[[6-(2,6-DIMETHYLPYRIDIN-3-YL)OXY-1-METHYL- HETNAM 2 B0X BENZIMIDAZOL-2-YL]METHOXY]BENZOIC ACID FORMUL 3 B0X C23 H21 N3 O4 FORMUL 4 HOH *171(H2 O) HELIX 1 AA1 GLU A 207 PHE A 226 1 20 HELIX 2 AA2 THR A 229 THR A 238 1 10 HELIX 3 AA3 ASP A 251 ILE A 262 1 12 HELIX 4 AA4 GLU A 276 LYS A 301 1 26 HELIX 5 AA5 GLY A 305 LEU A 309 5 5 HELIX 6 AA6 ASP A 310 LEU A 333 1 24 HELIX 7 AA7 ARG A 350 SER A 355 1 6 HELIX 8 AA8 PRO A 359 PHE A 363 5 5 HELIX 9 AA9 MET A 364 ALA A 376 1 13 HELIX 10 AB1 ASP A 380 LEU A 393 1 14 HELIX 11 AB2 ASN A 402 HIS A 425 1 24 HELIX 12 AB3 GLN A 430 GLU A 460 1 31 HELIX 13 AB4 HIS A 466 LYS A 474 1 9 HELIX 14 AB5 LEU C 8 ALA C 15 1 8 SHEET 1 AA1 4 PHE A 247 ILE A 249 0 SHEET 2 AA1 4 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249 SHEET 3 AA1 4 GLY A 338 ILE A 341 -1 N VAL A 339 O MET A 348 SHEET 4 AA1 4 MET A 334 ASN A 335 -1 N ASN A 335 O GLY A 338 CISPEP 1 LYS A 358 PRO A 359 0 -1.65 SITE 1 AC1 15 ILE A 249 PHE A 264 ARG A 280 ILE A 281 SITE 2 AC1 15 GLY A 284 CYS A 285 SER A 289 TYR A 327 SITE 3 AC1 15 ILE A 341 MET A 348 PHE A 363 MET A 364 SITE 4 AC1 15 LYS A 367 HIS A 449 HOH A 672 CRYST1 39.012 54.266 66.727 90.00 92.51 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025633 0.000000 0.001124 0.00000 SCALE2 0.000000 0.018428 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015001 0.00000